ClinicalTrials.gg
RecruitingNCT06557317BGW In-PersonUpdated Aug 16, 2024

In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes

An interventional study of Black Girls for Wellness In-Person in Behavior, Adolescent, Childhood Obesity and Diabetes Mellitus, Type 2, sponsored by Cornell University. Recruiting at 1 site in United States. Open to female participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2024-08-16.

Sponsored by Cornell University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
12 Years to 18 Years
Sex
Female
01

Study summary

The aim of this study is to look at changes in diabetes-related risk factors in Black adolescent girls who are at risk for type 2 diabetes and their primary female caregiver after both participating in a 12-week in-person lifestyle program.

Read the detailed description

Enrolled adolescent/caregiver dyads will participate in the 12-week program. Each week, participants will engage in 2 activities: an in-person Wellness Session and an at-home cooking experience using ingredients provided at the Wellness Session.

The study will examine the pre-post difference in overall diet quality, dermal carotenoid levels, physical activity, body composition, and glycemic measures among at-risk black adolescent girls and their caregivers. Investigators hypothesize that after the program, participants' diets will be higher in quality than before.

02

Conditions studied

  • Behavior, Adolescent
  • Childhood Obesity
  • Diabetes Mellitus, Type 2
  • Pediatric Obesity
  • Glucose Metabolism Disorders
  • Metabolic Disease
  • Endocrine System Diseases
  • Overweight
  • Overnutrition
  • Nutrition Disorders
  • Body Weight
  • Diabetes Mellitus

Keywords

  • Adolescents
  • In-Person Lifestyle Program
  • Diabetes prevention
  • Black girls
  • Obesity
03

In context

Adolescent Behavior

305 studies on the registry are indexed under Adolescent Behavior; 47 are open to participants now.

This study's planned enrollment of 60 is below the median of 172 across 256 interventional studies indexed under Adolescent Behavior.

Browse Adolescent Behavior studies →

Lead sponsor

Cornell University is the lead sponsor of 103 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria for adolescent participants:

  • 12-18 years of age
  • self-identify as Black or African American
  • have obesity (>=95th percentile )

Exclusion Criteria for adolescent participants:

  • pregnant or within 3 months postpartum.
  • participated in a formal weight management program within 6 months prior to study.
  • currently taking medications or diagnosed with a condition known to influence metabolism, physical activity ability, or cognitive function.
  • have previously undergone bariatric surgery.
  • have type 2 diabetes.
  • unable to speak English or have developmental conditions that interfere with ability to communicate.

Inclusion Criteria for caregiver participants:

  • 18 years or older.
  • proficiency in speaking English.
  • live in the same household as the adolescent who will also be enrolled.
  • prepares the majority (>50%) of meals in the household.

Exclusion Criteria for caregiver participants:

  • pregnant or within 3 months postpartum.
  • unable to speak English or have developmental conditions that interfere with ability to communicate.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Intervention Adolescent/Caregiver Dyads

    Adolescent/Caregiver dyads receive 12-week in-person lifestyle program consisting of a Wellness session, Dance Classes, and an at-home Cooking Experience.

    Behavioral: Black Girls for Wellness In-Person

Interventions

  • BehavioralBlack Girls for Wellness In-Person

    Weekly for 12 weeks, adolescent/caregiver dyads will attend 1) an in-person Wellness Session (mindfulness, nutrition lesson, dance class, program reflection) (90 min/wk) and 2) a home cooking experience using ingredients provided at the Wellness Session (60 min/wk).

06

What researchers measure

Primary outcomes

  1. Change in diet quality of adolescent participants, as measured by the Healthy Eating Index Scores

    Scores are calculated from three 24-hour diet records, range from 0-100. Higher score reflects that higher alignment between one's diet and dietary recommendations from the Dietary Guidelines for Americans.

    Time frame: Baseline, 12 weeks [end of study]

Secondary outcomes

  1. Change in dermal carotenoids level

    Scores are measured using the Veggie Meter device, range from 0-800. Higher score acts as proxy for fruits and vegetables consumption.

    Time frame: Baseline, 12 weeks [end of study]

  2. Change in percent time sedentary

    Accelerometry data will be collected from wrist accelerometers worn by participants for 7 days. Percent time spent on sedentary will be calculated.

    Time frame: Baseline, 12 weeks [end of study]

  3. Change in percent time spent in light activity

    Accelerometry data will be collected from wrist accelerometers worn by participants for 7 days. Percent time spent in light activity will be calculated.

    Time frame: Baseline, 12 weeks [end of study]

  4. Change in percent time spent in moderate to vigorous activity

    Accelerometry data will be collected from wrist accelerometers worn by participants for 7 days. Percent time spent in moderate and vigorous activity will be calculated.

    Time frame: Baseline, 12 weeks [end of study]

  5. Change in HbA1c

    HbA1c will be assessed through a blood draw.

    Time frame: Baseline, 12 weeks [end of study]

  6. Change in lipid profile

    Total, high-density, low-density cholesterol, and triglycerides will be assessed through a blood draws.

    Time frame: Baseline, 12 weeks [end of study]

  7. Change in body mass index

    Height will be measured using a stadiometer to the nearest decimal point in cm. Weight will be measured using a scale to the nearest decimal in kg. Body mass index will be calculated using kg/m\^2.

    Time frame: Baseline, 12 weeks [end of study]

  8. Change in body fat percentage

    Body fat percentage will be measured using a scale to the nearest decimal.

    Time frame: Baseline, 12 weeks [end of study]

  9. Change in waist circumference

    Waist circumference will be measured using a waist circumference tape to the nearest decimal in cm.

    Time frame: Baseline, 12 weeks [end of study]

  10. Change in high blood pressure status

    Blood pressure will be measured using blood pressure monitors. High blood pressure is considered as reading of \>=120/80.

    Time frame: Baseline, 12 weeks [end of study]

07

Study locations

1 of 1 sites recruiting
  • Brownsville Neighborhood Health Action Center
    Brooklyn, New York 11212, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2024; primary completion for Dec 2024, 4 months later.

Of 195 non-industry interventional studies with no phase under Adolescent Behavior, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 43. This study's planned 4 months is below that.

Counting every sponsor, half of 198 studies reached it within 20 months; a quarter within 8 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 14, 2024
First posted
Aug 16, 2024
StartEst.
Aug 2024
Primary completionEst.
Dec 31, 2024
CompletionEst.
Dec 31, 2024
Last update
Aug 16, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06557317
Lead sponsor
Cornell University
Responsible party
Sponsor
First posted
Aug 16, 2024
Start date
Aug 2024 (estimated)
Primary completion
Dec 31, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Aug 16, 2024

Study contacts

Tashara M Leak, PhD, RD
Contact
tml226@cornell.edu
607-255-7664
Tashara M Leak, PhD, RD
principal investigator · Cornell University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion